IE
Insider Edges

REGENERON PHARMACEUTICALS, INC. 13F portfolio summary

REGENERON PHARMACEUTICALS, INC. of REGENERON PHARMACEUTICALS, INC. has 3 current stock holdings with a reported portfolio value of $177.2M. The portfolio 1 year return is +151.28%. Top holdings include NTLA (35.35%).

Back to investors

REGENERON PHARMACEUTICALS, INC. 13F Portfolio

REGENERON PHARMACEUTICALS, INC.
Latest SEC 13F filing: 2026-06-30

REGENERON PHARMACEUTICALS, INC. runs REGENERON PHARMACEUTICALS, INC. and currently holds 3 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $177.22M. Their top holdings are NTLA. The top five represent 35.4% of reported portfolio weight. REGENERON PHARMACEUTICALS, INC. ranks #46 out of 1000 investors tracked by Alpha Score. Their current best-performing preview position is NTLA with returns of +31.98%.

Sign in to enable email alerts for this investor.
Top 5 Holdings
NTLA35.4%
Top 5: 35.4%
Portfolio Returns
1 Year
+151.28%
#29/1000
3 Year
+242.33%
#52/1000
5 Year
+242.33%
#47/1000

Portfolio Value

$177.22M

Alpha Score

203.1

#46 of 1000

Holdings

3

Showper page

REGENERON PHARMACEUTICALS, INC. Current 13F Holdings

Reported holdings from REGENERON PHARMACEUTICALS, INC.'s latest SEC 13F filing, ranked by portfolio weight.

3 stock holdings

HoldingWeightAvg BuyCurrentReturnQuarter Change
NTLA
Intellia Therapeutics, Inc.
35.35%$11.66$13.07+12.09%
Held